0.1010
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Daniel S. McKinney | Founder, Chairman & CEO | -- | -- | 1962 |
EV Biologics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 284
Description
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
Corporate Governance
EV Biologics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
November 9, 2017 at 12:00 AM UTC
Dividend Date
Related Tickers
CLCS Cell Source, Inc.
0.2815
-6.17%
ISCO International Stem Cell Corporation
0.1100
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0024
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
ENZN Enzon Pharmaceuticals, Inc.
0.1500
+15.38%
PBLA Panbela Therapeutics, Inc.
0.3252
-14.40%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
RLMD Relmada Therapeutics, Inc.
0.3540
-2.88%
HCWB HCW Biologics Inc.
0.2748
+6.06%